<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) commonly exhibits Epstein-Barr virus (EBV) positivity associated with latent <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Models of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> have been associated with cellular resistance to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>However, the effect of latent long-term <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> on <z:mpath ids='MPATH_3'>apoptosis</z:mpath> induced by drugs is not well defined </plain></SENT>
<SENT sid="3" pm="."><plain>To determine this, we have studied the response of the Akata EBV+ cell line (type I latency) to <z:chebi fb="0" ids="4911">etoposide</z:chebi>, before and after downregulating EBV gene expression </plain></SENT>
<SENT sid="4" pm="."><plain>We observed that downregulating EBV nuclear antigen-1 (EBNA-1) expression with siRNAs reverted cellular sensitivity to <z:chebi fb="0" ids="4911">etoposide</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>In accordance with this finding, Akata EBV+ cells showed increased sensitivity to <z:chebi fb="0" ids="4911">etoposide</z:chebi>, when compared to the Akata EBV- cells </plain></SENT>
<SENT sid="6" pm="."><plain>We also observed that Akata EBV+ cells presented <z:mp ids='MP_0006042'>increased apoptosis</z:mp> levels and decreased Bcl-xL <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein levels, when compared to the Akata EBV- cells </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, Akata EBV+ cells contained less endoplasmic reticulum (ER) than EBV- cells </plain></SENT>
<SENT sid="8" pm="."><plain>Finally, downregulation of EBV with EBNA-1 siRNAs caused an increase in the expression of Bcl-xL indicating that EBV is responsible for the differences found between the Akata EBV+ and EBV- cell lines </plain></SENT>
</text></document>